Call Us For More Information


Innovation for Cellular Therapies

Vycellix™, Inc. is a closely-held biopharmaceutical company advancing innovative, immune-modulating small molecules designed to enhance innate and adaptive cellular therapies, facilitate cell therapy manufacturing processes and optimize human immune response against disease with a focus on cancers.

Our pipeline significantly impacts next-generation immune cell based therapies, redefining the manufacturing paradigm to maximize cost and speed efficiencies, as well as amplifying T cells and NK cells into more potent disease-targeting lymphocytes, which we have branded as Amplicytes™.

Comments are closed.